VELTIS Trademark

Trademark Overview


On Tuesday, June 24, 2025, a trademark application was filed for VELTIS with the United States Patent and Trademark Office. The USPTO has given the VELTIS trademark a serial number of 99250298. The federal status of this trademark filing is RESPONSE AFTER NON-FINAL ACTION - ENTERED as of Wednesday, May 6, 2026. This trademark is owned by Sartorius Albumedix Limited. The VELTIS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, urinary, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, hematological, ophthalmic, respiratory, digestive, neurological, gastrointestinal, hormonal, dermatological and immune system related diseases and disorders; Reagents for pharmaceutical use, namely, ingredients used in the manufacture, formulation, stabilization, solubilization and preservation of therapeutic preparations and vaccines; Reagents for medical use; Diagnostic reagents for medical use; Proteins for pharmaceutical and medical purposes, namely, human and synthetic proteins, therapeutic proteins, recombinant albumin, human serum albumin and recombinant human albumin for use as cellular absorption, enzyme stabilizers and anti-coagulant agents in the testing and manufacture of pharmaceuticals and for medical laboratory use; Albumin for pharmaceutical and medical purpo...
veltis

General Information


Serial Number99250298
Word MarkVELTIS
Filing DateTuesday, June 24, 2025
Status661 - RESPONSE AFTER NON-FINAL ACTION - ENTERED
Status DateWednesday, May 6, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesPharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, urinary, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, hematological, ophthalmic, respiratory, digestive, neurological, gastrointestinal, hormonal, dermatological and immune system related diseases and disorders; Reagents for pharmaceutical use, namely, ingredients used in the manufacture, formulation, stabilization, solubilization and preservation of therapeutic preparations and vaccines; Reagents for medical use; Diagnostic reagents for medical use; Proteins for pharmaceutical and medical purposes, namely, human and synthetic proteins, therapeutic proteins, recombinant albumin, human serum albumin and recombinant human albumin for use as cellular absorption, enzyme stabilizers and anti-coagulant agents in the testing and manufacture of pharmaceuticals and for medical laboratory use; Albumin for pharmaceutical and medical purposes, namely, recombinant human albumin sold as an integral component of a vaccine and pharmaceuticals for the treatment of viral, metabolic, endocrine, urinary, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, hematological, ophthalmic, respiratory, digestive, neurological, gastrointestinal, hormonal, dermatological and immune system related diseases and disorders; Recombinant albumin for use as a reagent for medical purposes; Diagnostic contrast agents for medical imaging

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, June 24, 2025
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameSartorius Albumedix Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressNottingham NG23ED
GB

Trademark Events


Event DateEvent Description
Tuesday, June 24, 2025NEW APPLICATION ENTERED
Tuesday, June 24, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, June 24, 2025APPLICATION FILING RECEIPT MAILED
Thursday, August 7, 2025TEAS VOLUNTARY AMENDMENT RECEIVED
Thursday, August 7, 2025TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED
Thursday, November 13, 2025ASSIGNED TO EXAMINER
Friday, November 21, 2025NON-FINAL ACTION WRITTEN
Friday, November 21, 2025NON-FINAL ACTION E-MAILED
Friday, November 21, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, February 11, 2026APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Wednesday, February 11, 2026APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Wednesday, May 6, 2026TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, May 6, 2026CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, May 6, 2026TEAS/EMAIL CORRESPONDENCE ENTERED